ror1 Search Results


85
Thermo Fisher gene exp ror1 hs00178178 m1
Gene Exp Ror1 Hs00178178 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp ror1 hs00178178 m1/product/Thermo Fisher
Average 85 stars, based on 1 article reviews
gene exp ror1 hs00178178 m1 - by Bioz Stars, 2026-03
85/100 stars
  Buy from Supplier

94
Miltenyi Biotec ror1
Ror1, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ror1/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
ror1 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology anti ror1 antibody
Anti Ror1 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti ror1 antibody/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
anti ror1 antibody - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc ror1
Apoptosis signal‐regulating kinase 1 (ASK1)‐mediated signaling is involved, at least in part, in receptor tyrosine kinase‐like orphan receptor 1 <t>(ROR1)</t> siRNA‐induced growth inhibition. Effects of co‐treatment with siASK1 and siROR1 in (a) PC‐9 and (b) NCI‐H1975 cells. Colorimetric (top panel) and Western blot (bottom panel) analyses were carried out at 5 and 3 days, respectively, after co‐transfection. Data are shown as the mean ± SEM ( n = 3). * P < 0.05.
Ror1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ror1/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
ror1 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc anti ror1
Apoptosis signal‐regulating kinase 1 (ASK1)‐mediated signaling is involved, at least in part, in receptor tyrosine kinase‐like orphan receptor 1 <t>(ROR1)</t> siRNA‐induced growth inhibition. Effects of co‐treatment with siASK1 and siROR1 in (a) PC‐9 and (b) NCI‐H1975 cells. Colorimetric (top panel) and Western blot (bottom panel) analyses were carried out at 5 and 3 days, respectively, after co‐transfection. Data are shown as the mean ± SEM ( n = 3). * P < 0.05.
Anti Ror1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti ror1/product/Cell Signaling Technology Inc
Average 94 stars, based on 1 article reviews
anti ror1 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology ror1
<t>ROR1</t> is a therapeutic target for osteosarcoma stem cells. (A) Expression array correlation data showing a significantly positive correlation between WNT5B and ROR1 in osteosarcoma samples. Data were analysed using the R2 genomics analysis and visualization platform, and data generated by Kuijjer et al. <xref ref-type= 18 n = 127, p < 3.5 × 10 −14 . (B) Representative images of immunohistochemistry on an osteosarcoma tissue microarray stained for ROR1 and WNT5B. Matched images from two samples, one low for both WNT5B and ROR1 and one high for both WNT5B and ROR1. n = 40 cores in duplicate, scale bar = 400 µm. (C) Correlation graph of osteosarcoma tissue microarray depicted in (B. Average immune reactive scoring of all WNT5B and ROR1 cores indicates a positive correlation between WNT5B and ROR1 in osteosarcoma patient samples. n = 40 cores, p = .0007. (D) Immunofluorescence of 143B adherent cells and spheres. 10× microscopy images, WNT5B = green, ROR1 = red, DAPI nuclear stain = blue. White arrows indicate areas of WNT5B/ROR1 colocalisation (yellow), scale bar = 400 µm. (E) 143B spheres treated with siRNA to ROR1 or scrambled siRNA for 72 h. Sphere size quantified using ImageJ. n = > 380 spheres per group, **** p < .0001. (F) 143B spheres treated with 100 µg/mL D10 and/or 50 ng/mL rWNT5B for 48 h. The sphere area was quantified using ImageJ. n ≥ 80 spheres per group, * p < .05. (G) 143B spheres treated with a low dose of (40 µg/mL) D10 and/or high dose (10 µg/mL) MTX for 48 h to assess reduction in chemoresistance. The sphere area was quantified using ImageJ. n ≥ 110 spheres per group, * p < .05, **** p < .0001. (H) PDX‐derived spheres treated with increasing doses (0, 10, 40, 100 µg/mL) of D10. Sphere area quantified using ImageJ. n ≥ 210 spheres per group, ** p < .01. (I) SOX2 western blot of 143B spheres control, spheres treated with 40 µg/mL D10 for 48 h, and 143B WNT5B KO spheres. (J) ImageJ quantification of the western blot in (I). * p < .05, ** p < .01, ns = not significant. Normalised to β‐Actin, n = 3 experimental replicates. PDX, Patient‐derived xenograft; MTX, methotrexate. " width="250" height="auto" />
Ror1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ror1/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
ror1 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Proteintech anti ror1
<t>ROR1</t> is a therapeutic target for osteosarcoma stem cells. (A) Expression array correlation data showing a significantly positive correlation between WNT5B and ROR1 in osteosarcoma samples. Data were analysed using the R2 genomics analysis and visualization platform, and data generated by Kuijjer et al. <xref ref-type= 18 n = 127, p < 3.5 × 10 −14 . (B) Representative images of immunohistochemistry on an osteosarcoma tissue microarray stained for ROR1 and WNT5B. Matched images from two samples, one low for both WNT5B and ROR1 and one high for both WNT5B and ROR1. n = 40 cores in duplicate, scale bar = 400 µm. (C) Correlation graph of osteosarcoma tissue microarray depicted in (B. Average immune reactive scoring of all WNT5B and ROR1 cores indicates a positive correlation between WNT5B and ROR1 in osteosarcoma patient samples. n = 40 cores, p = .0007. (D) Immunofluorescence of 143B adherent cells and spheres. 10× microscopy images, WNT5B = green, ROR1 = red, DAPI nuclear stain = blue. White arrows indicate areas of WNT5B/ROR1 colocalisation (yellow), scale bar = 400 µm. (E) 143B spheres treated with siRNA to ROR1 or scrambled siRNA for 72 h. Sphere size quantified using ImageJ. n = > 380 spheres per group, **** p < .0001. (F) 143B spheres treated with 100 µg/mL D10 and/or 50 ng/mL rWNT5B for 48 h. The sphere area was quantified using ImageJ. n ≥ 80 spheres per group, * p < .05. (G) 143B spheres treated with a low dose of (40 µg/mL) D10 and/or high dose (10 µg/mL) MTX for 48 h to assess reduction in chemoresistance. The sphere area was quantified using ImageJ. n ≥ 110 spheres per group, * p < .05, **** p < .0001. (H) PDX‐derived spheres treated with increasing doses (0, 10, 40, 100 µg/mL) of D10. Sphere area quantified using ImageJ. n ≥ 210 spheres per group, ** p < .01. (I) SOX2 western blot of 143B spheres control, spheres treated with 40 µg/mL D10 for 48 h, and 143B WNT5B KO spheres. (J) ImageJ quantification of the western blot in (I). * p < .05, ** p < .01, ns = not significant. Normalised to β‐Actin, n = 3 experimental replicates. PDX, Patient‐derived xenograft; MTX, methotrexate. " width="250" height="auto" />
Anti Ror1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti ror1/product/Proteintech
Average 93 stars, based on 1 article reviews
anti ror1 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

96
R&D Systems polyclonal goat
<t>ROR1</t> is a therapeutic target for osteosarcoma stem cells. (A) Expression array correlation data showing a significantly positive correlation between WNT5B and ROR1 in osteosarcoma samples. Data were analysed using the R2 genomics analysis and visualization platform, and data generated by Kuijjer et al. <xref ref-type= 18 n = 127, p < 3.5 × 10 −14 . (B) Representative images of immunohistochemistry on an osteosarcoma tissue microarray stained for ROR1 and WNT5B. Matched images from two samples, one low for both WNT5B and ROR1 and one high for both WNT5B and ROR1. n = 40 cores in duplicate, scale bar = 400 µm. (C) Correlation graph of osteosarcoma tissue microarray depicted in (B. Average immune reactive scoring of all WNT5B and ROR1 cores indicates a positive correlation between WNT5B and ROR1 in osteosarcoma patient samples. n = 40 cores, p = .0007. (D) Immunofluorescence of 143B adherent cells and spheres. 10× microscopy images, WNT5B = green, ROR1 = red, DAPI nuclear stain = blue. White arrows indicate areas of WNT5B/ROR1 colocalisation (yellow), scale bar = 400 µm. (E) 143B spheres treated with siRNA to ROR1 or scrambled siRNA for 72 h. Sphere size quantified using ImageJ. n = > 380 spheres per group, **** p < .0001. (F) 143B spheres treated with 100 µg/mL D10 and/or 50 ng/mL rWNT5B for 48 h. The sphere area was quantified using ImageJ. n ≥ 80 spheres per group, * p < .05. (G) 143B spheres treated with a low dose of (40 µg/mL) D10 and/or high dose (10 µg/mL) MTX for 48 h to assess reduction in chemoresistance. The sphere area was quantified using ImageJ. n ≥ 110 spheres per group, * p < .05, **** p < .0001. (H) PDX‐derived spheres treated with increasing doses (0, 10, 40, 100 µg/mL) of D10. Sphere area quantified using ImageJ. n ≥ 210 spheres per group, ** p < .01. (I) SOX2 western blot of 143B spheres control, spheres treated with 40 µg/mL D10 for 48 h, and 143B WNT5B KO spheres. (J) ImageJ quantification of the western blot in (I). * p < .05, ** p < .01, ns = not significant. Normalised to β‐Actin, n = 3 experimental replicates. PDX, Patient‐derived xenograft; MTX, methotrexate. " width="250" height="auto" />
Polyclonal Goat, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal goat/product/R&D Systems
Average 96 stars, based on 1 article reviews
polyclonal goat - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

93
R&D Systems anti ror1 antibody
<t>ROR1</t> is a therapeutic target for osteosarcoma stem cells. (A) Expression array correlation data showing a significantly positive correlation between WNT5B and ROR1 in osteosarcoma samples. Data were analysed using the R2 genomics analysis and visualization platform, and data generated by Kuijjer et al. <xref ref-type= 18 n = 127, p < 3.5 × 10 −14 . (B) Representative images of immunohistochemistry on an osteosarcoma tissue microarray stained for ROR1 and WNT5B. Matched images from two samples, one low for both WNT5B and ROR1 and one high for both WNT5B and ROR1. n = 40 cores in duplicate, scale bar = 400 µm. (C) Correlation graph of osteosarcoma tissue microarray depicted in (B. Average immune reactive scoring of all WNT5B and ROR1 cores indicates a positive correlation between WNT5B and ROR1 in osteosarcoma patient samples. n = 40 cores, p = .0007. (D) Immunofluorescence of 143B adherent cells and spheres. 10× microscopy images, WNT5B = green, ROR1 = red, DAPI nuclear stain = blue. White arrows indicate areas of WNT5B/ROR1 colocalisation (yellow), scale bar = 400 µm. (E) 143B spheres treated with siRNA to ROR1 or scrambled siRNA for 72 h. Sphere size quantified using ImageJ. n = > 380 spheres per group, **** p < .0001. (F) 143B spheres treated with 100 µg/mL D10 and/or 50 ng/mL rWNT5B for 48 h. The sphere area was quantified using ImageJ. n ≥ 80 spheres per group, * p < .05. (G) 143B spheres treated with a low dose of (40 µg/mL) D10 and/or high dose (10 µg/mL) MTX for 48 h to assess reduction in chemoresistance. The sphere area was quantified using ImageJ. n ≥ 110 spheres per group, * p < .05, **** p < .0001. (H) PDX‐derived spheres treated with increasing doses (0, 10, 40, 100 µg/mL) of D10. Sphere area quantified using ImageJ. n ≥ 210 spheres per group, ** p < .01. (I) SOX2 western blot of 143B spheres control, spheres treated with 40 µg/mL D10 for 48 h, and 143B WNT5B KO spheres. (J) ImageJ quantification of the western blot in (I). * p < .05, ** p < .01, ns = not significant. Normalised to β‐Actin, n = 3 experimental replicates. PDX, Patient‐derived xenograft; MTX, methotrexate. " width="250" height="auto" />
Anti Ror1 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti ror1 antibody/product/R&D Systems
Average 93 stars, based on 1 article reviews
anti ror1 antibody - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Addgene inc rhs4430 200224719 phage ror1 addgene
<t>ROR1</t> is a therapeutic target for osteosarcoma stem cells. (A) Expression array correlation data showing a significantly positive correlation between WNT5B and ROR1 in osteosarcoma samples. Data were analysed using the R2 genomics analysis and visualization platform, and data generated by Kuijjer et al. <xref ref-type= 18 n = 127, p < 3.5 × 10 −14 . (B) Representative images of immunohistochemistry on an osteosarcoma tissue microarray stained for ROR1 and WNT5B. Matched images from two samples, one low for both WNT5B and ROR1 and one high for both WNT5B and ROR1. n = 40 cores in duplicate, scale bar = 400 µm. (C) Correlation graph of osteosarcoma tissue microarray depicted in (B. Average immune reactive scoring of all WNT5B and ROR1 cores indicates a positive correlation between WNT5B and ROR1 in osteosarcoma patient samples. n = 40 cores, p = .0007. (D) Immunofluorescence of 143B adherent cells and spheres. 10× microscopy images, WNT5B = green, ROR1 = red, DAPI nuclear stain = blue. White arrows indicate areas of WNT5B/ROR1 colocalisation (yellow), scale bar = 400 µm. (E) 143B spheres treated with siRNA to ROR1 or scrambled siRNA for 72 h. Sphere size quantified using ImageJ. n = > 380 spheres per group, **** p < .0001. (F) 143B spheres treated with 100 µg/mL D10 and/or 50 ng/mL rWNT5B for 48 h. The sphere area was quantified using ImageJ. n ≥ 80 spheres per group, * p < .05. (G) 143B spheres treated with a low dose of (40 µg/mL) D10 and/or high dose (10 µg/mL) MTX for 48 h to assess reduction in chemoresistance. The sphere area was quantified using ImageJ. n ≥ 110 spheres per group, * p < .05, **** p < .0001. (H) PDX‐derived spheres treated with increasing doses (0, 10, 40, 100 µg/mL) of D10. Sphere area quantified using ImageJ. n ≥ 210 spheres per group, ** p < .01. (I) SOX2 western blot of 143B spheres control, spheres treated with 40 µg/mL D10 for 48 h, and 143B WNT5B KO spheres. (J) ImageJ quantification of the western blot in (I). * p < .05, ** p < .01, ns = not significant. Normalised to β‐Actin, n = 3 experimental replicates. PDX, Patient‐derived xenograft; MTX, methotrexate. " width="250" height="auto" />
Rhs4430 200224719 Phage Ror1 Addgene, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rhs4430 200224719 phage ror1 addgene/product/Addgene inc
Average 93 stars, based on 1 article reviews
rhs4430 200224719 phage ror1 addgene - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
OriGene rorα isoform 1 cdna
<t>ROR1</t> is a therapeutic target for osteosarcoma stem cells. (A) Expression array correlation data showing a significantly positive correlation between WNT5B and ROR1 in osteosarcoma samples. Data were analysed using the R2 genomics analysis and visualization platform, and data generated by Kuijjer et al. <xref ref-type= 18 n = 127, p < 3.5 × 10 −14 . (B) Representative images of immunohistochemistry on an osteosarcoma tissue microarray stained for ROR1 and WNT5B. Matched images from two samples, one low for both WNT5B and ROR1 and one high for both WNT5B and ROR1. n = 40 cores in duplicate, scale bar = 400 µm. (C) Correlation graph of osteosarcoma tissue microarray depicted in (B. Average immune reactive scoring of all WNT5B and ROR1 cores indicates a positive correlation between WNT5B and ROR1 in osteosarcoma patient samples. n = 40 cores, p = .0007. (D) Immunofluorescence of 143B adherent cells and spheres. 10× microscopy images, WNT5B = green, ROR1 = red, DAPI nuclear stain = blue. White arrows indicate areas of WNT5B/ROR1 colocalisation (yellow), scale bar = 400 µm. (E) 143B spheres treated with siRNA to ROR1 or scrambled siRNA for 72 h. Sphere size quantified using ImageJ. n = > 380 spheres per group, **** p < .0001. (F) 143B spheres treated with 100 µg/mL D10 and/or 50 ng/mL rWNT5B for 48 h. The sphere area was quantified using ImageJ. n ≥ 80 spheres per group, * p < .05. (G) 143B spheres treated with a low dose of (40 µg/mL) D10 and/or high dose (10 µg/mL) MTX for 48 h to assess reduction in chemoresistance. The sphere area was quantified using ImageJ. n ≥ 110 spheres per group, * p < .05, **** p < .0001. (H) PDX‐derived spheres treated with increasing doses (0, 10, 40, 100 µg/mL) of D10. Sphere area quantified using ImageJ. n ≥ 210 spheres per group, ** p < .01. (I) SOX2 western blot of 143B spheres control, spheres treated with 40 µg/mL D10 for 48 h, and 143B WNT5B KO spheres. (J) ImageJ quantification of the western blot in (I). * p < .05, ** p < .01, ns = not significant. Normalised to β‐Actin, n = 3 experimental replicates. PDX, Patient‐derived xenograft; MTX, methotrexate. " width="250" height="auto" />
Rorα Isoform 1 Cdna, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rorα isoform 1 cdna/product/OriGene
Average 90 stars, based on 1 article reviews
rorα isoform 1 cdna - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

94
Miltenyi Biotec ror1 apc conjugated antibody
<t>ROR1</t> is a therapeutic target for osteosarcoma stem cells. (A) Expression array correlation data showing a significantly positive correlation between WNT5B and ROR1 in osteosarcoma samples. Data were analysed using the R2 genomics analysis and visualization platform, and data generated by Kuijjer et al. <xref ref-type= 18 n = 127, p < 3.5 × 10 −14 . (B) Representative images of immunohistochemistry on an osteosarcoma tissue microarray stained for ROR1 and WNT5B. Matched images from two samples, one low for both WNT5B and ROR1 and one high for both WNT5B and ROR1. n = 40 cores in duplicate, scale bar = 400 µm. (C) Correlation graph of osteosarcoma tissue microarray depicted in (B. Average immune reactive scoring of all WNT5B and ROR1 cores indicates a positive correlation between WNT5B and ROR1 in osteosarcoma patient samples. n = 40 cores, p = .0007. (D) Immunofluorescence of 143B adherent cells and spheres. 10× microscopy images, WNT5B = green, ROR1 = red, DAPI nuclear stain = blue. White arrows indicate areas of WNT5B/ROR1 colocalisation (yellow), scale bar = 400 µm. (E) 143B spheres treated with siRNA to ROR1 or scrambled siRNA for 72 h. Sphere size quantified using ImageJ. n = > 380 spheres per group, **** p < .0001. (F) 143B spheres treated with 100 µg/mL D10 and/or 50 ng/mL rWNT5B for 48 h. The sphere area was quantified using ImageJ. n ≥ 80 spheres per group, * p < .05. (G) 143B spheres treated with a low dose of (40 µg/mL) D10 and/or high dose (10 µg/mL) MTX for 48 h to assess reduction in chemoresistance. The sphere area was quantified using ImageJ. n ≥ 110 spheres per group, * p < .05, **** p < .0001. (H) PDX‐derived spheres treated with increasing doses (0, 10, 40, 100 µg/mL) of D10. Sphere area quantified using ImageJ. n ≥ 210 spheres per group, ** p < .01. (I) SOX2 western blot of 143B spheres control, spheres treated with 40 µg/mL D10 for 48 h, and 143B WNT5B KO spheres. (J) ImageJ quantification of the western blot in (I). * p < .05, ** p < .01, ns = not significant. Normalised to β‐Actin, n = 3 experimental replicates. PDX, Patient‐derived xenograft; MTX, methotrexate. " width="250" height="auto" />
Ror1 Apc Conjugated Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ror1 apc conjugated antibody/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
ror1 apc conjugated antibody - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

Image Search Results


Apoptosis signal‐regulating kinase 1 (ASK1)‐mediated signaling is involved, at least in part, in receptor tyrosine kinase‐like orphan receptor 1 (ROR1) siRNA‐induced growth inhibition. Effects of co‐treatment with siASK1 and siROR1 in (a) PC‐9 and (b) NCI‐H1975 cells. Colorimetric (top panel) and Western blot (bottom panel) analyses were carried out at 5 and 3 days, respectively, after co‐transfection. Data are shown as the mean ± SEM ( n = 3). * P < 0.05.

Journal: Cancer Science

Article Title: Receptor tyrosine kinase‐like orphan receptor 1, a target of NKX2‐1/TTF‐1 lineage‐survival oncogene, inhibits apoptosis signal‐regulating kinase 1‐mediated pro‐apoptotic signaling in lung adenocarcinoma

doi: 10.1111/cas.12858

Figure Lengend Snippet: Apoptosis signal‐regulating kinase 1 (ASK1)‐mediated signaling is involved, at least in part, in receptor tyrosine kinase‐like orphan receptor 1 (ROR1) siRNA‐induced growth inhibition. Effects of co‐treatment with siASK1 and siROR1 in (a) PC‐9 and (b) NCI‐H1975 cells. Colorimetric (top panel) and Western blot (bottom panel) analyses were carried out at 5 and 3 days, respectively, after co‐transfection. Data are shown as the mean ± SEM ( n = 3). * P < 0.05.

Article Snippet: Anti‐ROR1, anti‐ASK1, anti‐phospho‐ASK1 (T845), anti‐phospho‐ASK1 (S83), anti‐MKK3/6, anti‐phospho‐MKK3/6 (S189/S207), anti‐p38, anti‐phospho‐p38 (T180/Y182), anti‐mouse IgG, and anti‐rabbit IgG were purchased from Cell Signaling Technology (Danvers, MA, USA).

Techniques: Inhibition, Western Blot, Cotransfection

Receptor tyrosine kinase‐like orphan receptor 1 (ROR1) suppresses reactive oxygen species‐induced apoptosis signal‐regulating kinase 1 (ASK1) and p38 phosphorylation. (a) Western blot (WB) analysis of ASK1 and p38 phosphorylation in MSTO‐211H cells stably transfected with an empty vector (VC #1 and VC #2), or an expression construct of wild‐type ROR1 (ROR1‐WT #1 and ROR1‐WT #2). (b) WB analysis of ASK1 and p38 phosphorylation in the presence or absence of H 2 O 2 in MSTO‐211H cells stably transfected with an empty or ROR1 expression vectors. (c) WB analysis of tert‐butyl hydroperoxide (TBHP)‐induced ASK1 and p38 phosphorylation in vector control or ROR1‐introduced MSTO‐211H cells. Arrowheads indicate non‐specific bands.

Journal: Cancer Science

Article Title: Receptor tyrosine kinase‐like orphan receptor 1, a target of NKX2‐1/TTF‐1 lineage‐survival oncogene, inhibits apoptosis signal‐regulating kinase 1‐mediated pro‐apoptotic signaling in lung adenocarcinoma

doi: 10.1111/cas.12858

Figure Lengend Snippet: Receptor tyrosine kinase‐like orphan receptor 1 (ROR1) suppresses reactive oxygen species‐induced apoptosis signal‐regulating kinase 1 (ASK1) and p38 phosphorylation. (a) Western blot (WB) analysis of ASK1 and p38 phosphorylation in MSTO‐211H cells stably transfected with an empty vector (VC #1 and VC #2), or an expression construct of wild‐type ROR1 (ROR1‐WT #1 and ROR1‐WT #2). (b) WB analysis of ASK1 and p38 phosphorylation in the presence or absence of H 2 O 2 in MSTO‐211H cells stably transfected with an empty or ROR1 expression vectors. (c) WB analysis of tert‐butyl hydroperoxide (TBHP)‐induced ASK1 and p38 phosphorylation in vector control or ROR1‐introduced MSTO‐211H cells. Arrowheads indicate non‐specific bands.

Article Snippet: Anti‐ROR1, anti‐ASK1, anti‐phospho‐ASK1 (T845), anti‐phospho‐ASK1 (S83), anti‐MKK3/6, anti‐phospho‐MKK3/6 (S189/S207), anti‐p38, anti‐phospho‐p38 (T180/Y182), anti‐mouse IgG, and anti‐rabbit IgG were purchased from Cell Signaling Technology (Danvers, MA, USA).

Techniques: Western Blot, Stable Transfection, Transfection, Plasmid Preparation, Expressing, Construct

Receptor tyrosine kinase‐like orphan receptor 1 (ROR1) inhibits apoptosis signal‐regulating kinase 1 (ASK1) kinase activity. Results of in vitro ASK1 kinase assays with use of myc‐tagged ASK1 immunoprecipitated from ASK1‐transfected 293T cells, as well as recombinant GST‐ROR1 and maltose‐binding protein–MAPKK 6 (MBP‐MKK6) proteins purified from Escherichia coli .

Journal: Cancer Science

Article Title: Receptor tyrosine kinase‐like orphan receptor 1, a target of NKX2‐1/TTF‐1 lineage‐survival oncogene, inhibits apoptosis signal‐regulating kinase 1‐mediated pro‐apoptotic signaling in lung adenocarcinoma

doi: 10.1111/cas.12858

Figure Lengend Snippet: Receptor tyrosine kinase‐like orphan receptor 1 (ROR1) inhibits apoptosis signal‐regulating kinase 1 (ASK1) kinase activity. Results of in vitro ASK1 kinase assays with use of myc‐tagged ASK1 immunoprecipitated from ASK1‐transfected 293T cells, as well as recombinant GST‐ROR1 and maltose‐binding protein–MAPKK 6 (MBP‐MKK6) proteins purified from Escherichia coli .

Article Snippet: Anti‐ROR1, anti‐ASK1, anti‐phospho‐ASK1 (T845), anti‐phospho‐ASK1 (S83), anti‐MKK3/6, anti‐phospho‐MKK3/6 (S189/S207), anti‐p38, anti‐phospho‐p38 (T180/Y182), anti‐mouse IgG, and anti‐rabbit IgG were purchased from Cell Signaling Technology (Danvers, MA, USA).

Techniques: Activity Assay, In Vitro, Immunoprecipitation, Transfection, Recombinant, Binding Assay, Purification

Receptor tyrosine kinase‐like orphan receptor 1 (ROR1) physically interacts with apoptosis signal‐regulating kinase 1 (ASK1). (a) Immunoprecipitation–Western blot (IP‐WB) analysis of interaction between ROR1 and ASK1 co‐introduced into 293T cells. (b) IP‐WB analysis of interaction of endogenous ASK1 with ROR1 introduced into MSTO‐211H cells. (c) IP‐WB analysis of interaction between endogenous ROR1 and ASK1 using lysates of PC‐9 and NCI‐H1975 cells. (d) IP‐WB analysis of interaction of endogenous ROR1 and ASK1 in presence or absence of H 2 O 2 in PC‐9 cells. VC, empty vector.

Journal: Cancer Science

Article Title: Receptor tyrosine kinase‐like orphan receptor 1, a target of NKX2‐1/TTF‐1 lineage‐survival oncogene, inhibits apoptosis signal‐regulating kinase 1‐mediated pro‐apoptotic signaling in lung adenocarcinoma

doi: 10.1111/cas.12858

Figure Lengend Snippet: Receptor tyrosine kinase‐like orphan receptor 1 (ROR1) physically interacts with apoptosis signal‐regulating kinase 1 (ASK1). (a) Immunoprecipitation–Western blot (IP‐WB) analysis of interaction between ROR1 and ASK1 co‐introduced into 293T cells. (b) IP‐WB analysis of interaction of endogenous ASK1 with ROR1 introduced into MSTO‐211H cells. (c) IP‐WB analysis of interaction between endogenous ROR1 and ASK1 using lysates of PC‐9 and NCI‐H1975 cells. (d) IP‐WB analysis of interaction of endogenous ROR1 and ASK1 in presence or absence of H 2 O 2 in PC‐9 cells. VC, empty vector.

Article Snippet: Anti‐ROR1, anti‐ASK1, anti‐phospho‐ASK1 (T845), anti‐phospho‐ASK1 (S83), anti‐MKK3/6, anti‐phospho‐MKK3/6 (S189/S207), anti‐p38, anti‐phospho‐p38 (T180/Y182), anti‐mouse IgG, and anti‐rabbit IgG were purchased from Cell Signaling Technology (Danvers, MA, USA).

Techniques: Immunoprecipitation, Western Blot, Plasmid Preparation

Fine mapping of apoptosis signal‐regulating kinase 1 (ASK1)‐interacting domain of receptor tyrosine kinase‐like orphan receptor 1 (ROR1). (a) Schematic diagram of deletion mutants of ROR1. Immunoprecipitation (IP)–Western blot analysis of COS‐7 cells co‐introduced with ASK1 and various forms of ROR1. ΔP, mutant lacking a proline‐rich region; ΔS/T1 and ΔS/T2, mutants lacking one of the two serine/threonine‐rich regions; TK∆1, TK∆2, and TK∆3, mutants lacking one‐third of the kinase domain; WT, wild‐type ROR1. (b) IP–Western blot analysis for fine mapping of ASK1‐interacting domain of ROR1.

Journal: Cancer Science

Article Title: Receptor tyrosine kinase‐like orphan receptor 1, a target of NKX2‐1/TTF‐1 lineage‐survival oncogene, inhibits apoptosis signal‐regulating kinase 1‐mediated pro‐apoptotic signaling in lung adenocarcinoma

doi: 10.1111/cas.12858

Figure Lengend Snippet: Fine mapping of apoptosis signal‐regulating kinase 1 (ASK1)‐interacting domain of receptor tyrosine kinase‐like orphan receptor 1 (ROR1). (a) Schematic diagram of deletion mutants of ROR1. Immunoprecipitation (IP)–Western blot analysis of COS‐7 cells co‐introduced with ASK1 and various forms of ROR1. ΔP, mutant lacking a proline‐rich region; ΔS/T1 and ΔS/T2, mutants lacking one of the two serine/threonine‐rich regions; TK∆1, TK∆2, and TK∆3, mutants lacking one‐third of the kinase domain; WT, wild‐type ROR1. (b) IP–Western blot analysis for fine mapping of ASK1‐interacting domain of ROR1.

Article Snippet: Anti‐ROR1, anti‐ASK1, anti‐phospho‐ASK1 (T845), anti‐phospho‐ASK1 (S83), anti‐MKK3/6, anti‐phospho‐MKK3/6 (S189/S207), anti‐p38, anti‐phospho‐p38 (T180/Y182), anti‐mouse IgG, and anti‐rabbit IgG were purchased from Cell Signaling Technology (Danvers, MA, USA).

Techniques: Immunoprecipitation, Western Blot, Mutagenesis

Receptor tyrosine kinase‐like orphan receptor 1 (ROR1) kinase activity is required for inhibition of reactive oxygen species‐elicited phosphorylation of apoptosis signal‐regulating kinase 1 (ASK1) and p38. (a) Western blot analysis of ASK1 and p38 phosphorylation in the presence or absence of H 2 O 2 in MSTO‐211H cells stably expressing wild‐type (WT) or kinase‐dead (KD) ROR1. Arrowheads indicate non‐specific bands. (b) Colorimetric assay of cell proliferation in MSTO‐211H transfectants in the presence or absence of H 2 O 2. (c) Representative results of flow cytometric analysis of apoptosis induction in ROR1‐transfected MSTO‐211H cells treated with H 2 O 2 . (d) Flow cytometric analysis of sub‐G 1 cells. Representative data from five independent experiments are shown as the mean ± SEM. * P < 0.05, ** P < 0.01 vs empty vector (VC), as determined by Student's t ‐test. PI, propidium iodide.

Journal: Cancer Science

Article Title: Receptor tyrosine kinase‐like orphan receptor 1, a target of NKX2‐1/TTF‐1 lineage‐survival oncogene, inhibits apoptosis signal‐regulating kinase 1‐mediated pro‐apoptotic signaling in lung adenocarcinoma

doi: 10.1111/cas.12858

Figure Lengend Snippet: Receptor tyrosine kinase‐like orphan receptor 1 (ROR1) kinase activity is required for inhibition of reactive oxygen species‐elicited phosphorylation of apoptosis signal‐regulating kinase 1 (ASK1) and p38. (a) Western blot analysis of ASK1 and p38 phosphorylation in the presence or absence of H 2 O 2 in MSTO‐211H cells stably expressing wild‐type (WT) or kinase‐dead (KD) ROR1. Arrowheads indicate non‐specific bands. (b) Colorimetric assay of cell proliferation in MSTO‐211H transfectants in the presence or absence of H 2 O 2. (c) Representative results of flow cytometric analysis of apoptosis induction in ROR1‐transfected MSTO‐211H cells treated with H 2 O 2 . (d) Flow cytometric analysis of sub‐G 1 cells. Representative data from five independent experiments are shown as the mean ± SEM. * P < 0.05, ** P < 0.01 vs empty vector (VC), as determined by Student's t ‐test. PI, propidium iodide.

Article Snippet: Anti‐ROR1, anti‐ASK1, anti‐phospho‐ASK1 (T845), anti‐phospho‐ASK1 (S83), anti‐MKK3/6, anti‐phospho‐MKK3/6 (S189/S207), anti‐p38, anti‐phospho‐p38 (T180/Y182), anti‐mouse IgG, and anti‐rabbit IgG were purchased from Cell Signaling Technology (Danvers, MA, USA).

Techniques: Activity Assay, Inhibition, Western Blot, Stable Transfection, Expressing, Colorimetric Assay, Transfection, Plasmid Preparation

ROR1 is a therapeutic target for osteosarcoma stem cells. (A) Expression array correlation data showing a significantly positive correlation between WNT5B and ROR1 in osteosarcoma samples. Data were analysed using the R2 genomics analysis and visualization platform, and data generated by Kuijjer et al. <xref ref-type= 18 n = 127, p < 3.5 × 10 −14 . (B) Representative images of immunohistochemistry on an osteosarcoma tissue microarray stained for ROR1 and WNT5B. Matched images from two samples, one low for both WNT5B and ROR1 and one high for both WNT5B and ROR1. n = 40 cores in duplicate, scale bar = 400 µm. (C) Correlation graph of osteosarcoma tissue microarray depicted in (B. Average immune reactive scoring of all WNT5B and ROR1 cores indicates a positive correlation between WNT5B and ROR1 in osteosarcoma patient samples. n = 40 cores, p = .0007. (D) Immunofluorescence of 143B adherent cells and spheres. 10× microscopy images, WNT5B = green, ROR1 = red, DAPI nuclear stain = blue. White arrows indicate areas of WNT5B/ROR1 colocalisation (yellow), scale bar = 400 µm. (E) 143B spheres treated with siRNA to ROR1 or scrambled siRNA for 72 h. Sphere size quantified using ImageJ. n = > 380 spheres per group, **** p < .0001. (F) 143B spheres treated with 100 µg/mL D10 and/or 50 ng/mL rWNT5B for 48 h. The sphere area was quantified using ImageJ. n ≥ 80 spheres per group, * p < .05. (G) 143B spheres treated with a low dose of (40 µg/mL) D10 and/or high dose (10 µg/mL) MTX for 48 h to assess reduction in chemoresistance. The sphere area was quantified using ImageJ. n ≥ 110 spheres per group, * p < .05, **** p < .0001. (H) PDX‐derived spheres treated with increasing doses (0, 10, 40, 100 µg/mL) of D10. Sphere area quantified using ImageJ. n ≥ 210 spheres per group, ** p < .01. (I) SOX2 western blot of 143B spheres control, spheres treated with 40 µg/mL D10 for 48 h, and 143B WNT5B KO spheres. (J) ImageJ quantification of the western blot in (I). * p < .05, ** p < .01, ns = not significant. Normalised to β‐Actin, n = 3 experimental replicates. PDX, Patient‐derived xenograft; MTX, methotrexate. " width="100%" height="100%">

Journal: Clinical and Translational Medicine

Article Title: WNT5B drives osteosarcoma stemness, chemoresistance and metastasis

doi: 10.1002/ctm2.1670

Figure Lengend Snippet: ROR1 is a therapeutic target for osteosarcoma stem cells. (A) Expression array correlation data showing a significantly positive correlation between WNT5B and ROR1 in osteosarcoma samples. Data were analysed using the R2 genomics analysis and visualization platform, and data generated by Kuijjer et al. 18 n = 127, p < 3.5 × 10 −14 . (B) Representative images of immunohistochemistry on an osteosarcoma tissue microarray stained for ROR1 and WNT5B. Matched images from two samples, one low for both WNT5B and ROR1 and one high for both WNT5B and ROR1. n = 40 cores in duplicate, scale bar = 400 µm. (C) Correlation graph of osteosarcoma tissue microarray depicted in (B. Average immune reactive scoring of all WNT5B and ROR1 cores indicates a positive correlation between WNT5B and ROR1 in osteosarcoma patient samples. n = 40 cores, p = .0007. (D) Immunofluorescence of 143B adherent cells and spheres. 10× microscopy images, WNT5B = green, ROR1 = red, DAPI nuclear stain = blue. White arrows indicate areas of WNT5B/ROR1 colocalisation (yellow), scale bar = 400 µm. (E) 143B spheres treated with siRNA to ROR1 or scrambled siRNA for 72 h. Sphere size quantified using ImageJ. n = > 380 spheres per group, **** p < .0001. (F) 143B spheres treated with 100 µg/mL D10 and/or 50 ng/mL rWNT5B for 48 h. The sphere area was quantified using ImageJ. n ≥ 80 spheres per group, * p < .05. (G) 143B spheres treated with a low dose of (40 µg/mL) D10 and/or high dose (10 µg/mL) MTX for 48 h to assess reduction in chemoresistance. The sphere area was quantified using ImageJ. n ≥ 110 spheres per group, * p < .05, **** p < .0001. (H) PDX‐derived spheres treated with increasing doses (0, 10, 40, 100 µg/mL) of D10. Sphere area quantified using ImageJ. n ≥ 210 spheres per group, ** p < .01. (I) SOX2 western blot of 143B spheres control, spheres treated with 40 µg/mL D10 for 48 h, and 143B WNT5B KO spheres. (J) ImageJ quantification of the western blot in (I). * p < .05, ** p < .01, ns = not significant. Normalised to β‐Actin, n = 3 experimental replicates. PDX, Patient‐derived xenograft; MTX, methotrexate.

Article Snippet: Cells were treated with 100 nM of either a scrambled control or ROR1 (Santa Cruz: sc‐76424) siRNA combined with Lipofectamine Reagent for 15 min and then added to the cells for transfection.

Techniques: Expressing, Generated, Immunohistochemistry, Microarray, Staining, Immunofluorescence, Microscopy, Derivative Assay, Western Blot, Control